LD-2 disclosure · 3rd Quarter - Report (No Activity)NEPHCUREvia NEPHCURE3rd Quarter (July 1 - Sep 30) · 2025Posted Nov 17, 2025Filing document ↗LDA record ↗Coverage · No income or expenses were reported on this filing.ClientNameNEPHCUREDescriptionRare kidney disease patient advocacy organizationLocationPennsylvania · United States of AmericaRegistrantFirmNEPHCURELocationPhiladelphia, Pennsylvania, United States of America